Literature DB >> 9016279

Major depression following smoking cessation.

L S Covey1, A H Glassman, F Stetner.   

Abstract

OBJECTIVE: The authors examined the incidence and predictors of major depression following successful smoking cessation treatment, with special attention to the influence of past major depression.
METHOD: Three-month follow-up data were obtained from 126 subjects who successfully completed a 10-week smoking cessation program.
RESULTS: The 3-month incidence of new major depression following treatment for nicotine dependence was 2%, 17%, and 30% among subjects with histories of no major depression, single major depression, and recurrent major depression, respectively. A history of major depression and persistent withdrawal symptoms independently predicted posttreatment major depression.
CONCLUSIONS: Continued patient care beyond the 2-4-week period associated with the nicotine withdrawal syndrome is indicated when abstinence is attempted by smokers with prior major depression.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9016279     DOI: 10.1176/ajp.154.2.263

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  65 in total

1.  Smoking cessation at the workplace. Results of a randomised controlled intervention study. Worksite physicians from the AIREL group.

Authors:  T Lang; V Nicaud; K Slama; A Hirsch; E Imbernon; M Goldberg; L Calvel; P Desobry; J P Favre-Trosson; C Lhopital; P Mathevon; D Miara; A Miliani; F Panthier; G Pons; C Roitg; M Thoores
Journal:  J Epidemiol Community Health       Date:  2000-05       Impact factor: 3.710

2.  Smoking and the Five-Factor Model of personality.

Authors:  Antonio Terracciano; Paul T Costa
Journal:  Addiction       Date:  2004-04       Impact factor: 6.526

Review 3.  Genetics of smoking and depression.

Authors:  Ming T Tsuang; Tracee Francis; Kyle Minor; Alison Thomas; William S Stone
Journal:  Hum Genet       Date:  2012-04-17       Impact factor: 4.132

Review 4.  Mouse models for studying genetic influences on factors determining smoking cessation success in humans.

Authors:  F Scott Hall; Athina Markou; Edward D Levin; George R Uhl
Journal:  Ann N Y Acad Sci       Date:  2012-02       Impact factor: 5.691

5.  Nicotine Addiction and Psychiatric Disorders.

Authors:  Munir Gunes Kutlu; Vinay Parikh; Thomas J Gould
Journal:  Int Rev Neurobiol       Date:  2015-09-19       Impact factor: 3.230

6.  Transdermal nicotine attenuates depression symptoms in nonsmokers: a double-blind, placebo-controlled trial.

Authors:  F Joseph McClernon; F Berry Hiott; Eric C Westman; Jed E Rose; Edward D Levin
Journal:  Psychopharmacology (Berl)       Date:  2006-09-15       Impact factor: 4.530

7.  Smoking and common mental disorders: a population-based survey in Santiago, Chile.

Authors:  Ricardo Araya; Jorge Gaete; Graciela Rojas; Rosemarie Fritsch; Glyn Lewis
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2007-08-03       Impact factor: 4.328

8.  Depression vulnerability moderates the effects of cognitive behavior therapy in a randomized controlled trial for smoking cessation.

Authors:  Heather Schloss Kapson; David A F Haaga
Journal:  Behav Ther       Date:  2010-05-05

Review 9.  Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent.

Authors:  Linda P Dwoskin; Anthony S Rauhut; Kelley A King-Pospisil; Michael T Bardo
Journal:  CNS Drug Rev       Date:  2006 Fall-Winter

Review 10.  Reducing the addictiveness of cigarettes. Council on Scientific Affairs, American Medical Association.

Authors:  J E Henningfield; N L Benowitz; J Slade; T P Houston; R M Davis; S D Deitchman
Journal:  Tob Control       Date:  1998       Impact factor: 7.552

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.